The cost, which is confidential and was negotiated for all in all , 300 huge number of doses, is somewhat lower than the $19.50 a photo the United States agreed to purchase a first shipment of hundred million doses of the identical vaccine, in line with what Reuters reported in November.
The EU document dated Nov. 18 was circulated internally after the EU announced the supply package of its with Pfizer and its German partner BioNTech on Nov. 11.
The EU drug regulator is anticipated to determine on Monday on approval for the Pfizer vaccine following the shot was authorised in several countries, like Britain and the United States.
On Thursday Belgian say secretary on your budget Eva De Bleeker released on Twitter a table with price tags Belgium would shell out pharmaceutical companies for the COVID 19 vaccines of theirs. She retracted the piece of writing shortly after publishing.
In that table the Pfizer vaccine was suggested as costing Belgium 12 euros ($14.6) per dose, top many to believe that has been the total price agreed by the EU.
Other vaccines in the family table were also shown with prices lower than prices disclosed by EU solutions.
“There is , naturally, a total fee and a price upon delivery,” an EU official involved in talks with vaccine creators told Reuters when asked to clarify the big difference between the EU and Belgian rates.
A spokesman for De Bleeker declined to comment on Monday, citing confidentiality requirements, but pointed to what De Bleeker told the Belgian parliament last week. In this public hearing, De Beeker said Belgium’s budgeted costs were still partial.
Underneath EU advance purchase deals for COVID 19 vaccines, the bloc believes upfront payments with business enterprises to secure doses before they’re approved. Following approvals, EU governments are able to pay the rest to purchase reserved doses.
The EU has not revealed the upfront transaction agreed with Pfizer.
However, it mentioned in October that it paid aproximatelly 1 billion euros inside downpayments to AstraZeneca, Sanofi and Johnson and Johnson for the shots of theirs, with an additional 1.45 billion euros budgeted for initial payments to Pfizer BioNTech, Moderna and Curevac.
It has since agreed source deals with all 6 companies and is negotiating a seventh arrangement with Novavax.